v3.26.1
Basis of Presentation (Tables)
3 Months Ended
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Revision on Previously Reported Financial Statements
The effect of the above revision on previously reported financial statements is presented below:
As previously reportedImpact of revisionAs revised
Consolidated statement of income for the three months ended March 31, 2025
Net gains on sales of loans$18,648 $(3,210)$15,438 
Total noninterest income25,581 (3,210)22,371 
Salaries and employee benefits$48,008 $(2,479)$45,529 
Travel expense2,795 (731)2,064 
Total noninterest expense84,017 (3,210)80,807 
Consolidated statement of cash flows for the three months ended March 31, 2025
Operating activities:
Net gains on sale of loans held for sale$(18,648)$3,210 $(15,438)
Net cash provided by operating activities(32,977)3,210 (29,767)
Investing activities:
Net change in loans and leases$(410,547)$(3,210)$(413,757)
Net cash used by investing activities(461,310)(3,210)(464,520)